Pre-clinical Support for Drug & Product Development
From Discovery to Clinic
Preclinical support is critical for reducing risk and improving success rates in clinical phases. Our services bridge the gap between discovery and clinical trials, ensuring data-driven decisions and regulatory alignment. We emphasise translational biomarkers and advanced modelling to optimise development strategies and accelerate timelines, and have our own clinical pharmacology units to take you to First-in-Human.
Our Services
- Drug & Product Development Planning
- PK/PD Modelling & Simulation
- Translational Modelling & Simulation
- Translational Biomarkers for decision-making
Why It Matters
Preclinical planning and modelling provide a strong foundation for clinical success. By leveraging PK/PD and translational modelling, we help predict outcomes, and reduce late-stage failures. Translational biomarkers serve as critical indicators, bridging preclinical insights to clinical applications, serving go/no go decisions.
Compliance & Expertise
Our workflows align with global regulatory expectations and utilise advanced modelling tools. We ensure that all strategies are scientifically robust and compliant with industry standards, supporting smooth transitions from preclinical to clinical phases. Our unique solution gives you one team from consulting, biostatistics, and science working together on your challenges.
Plan your next Clinical Trial with hVIVO
If you're a potential customer, find out how hVIVO can help you.